Zusammenfassung
Die diagnostischen und therapeutischen Möglichkeiten im Herzkatheterlabor ergeben sich erst aus der Applikation jodhaltigen Röntgenkontrastmittels und der Visualisierung mittels Röntgenstrahlung.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adams HA, Baumann G, Gansslen A et al. (2001) Definitionen der Schockformen. Anasthesiol Intensivmed Notfallmed Schmerzther. 36 Suppl 2: S 140–3
AGGREE-Collaboration (2003) Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument
Berwanger O (2010) Acetylcysteine for the Prevention of Contrast- Induced Nephropathy (ACT) Trial: A Pragmatic Multicenter Randomized Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Renal Outcomes in Patients Undergoing Coronary and Vascular Angiography Abstract 21843, Tuesday, November 16, 11:51-12:01. American Heart Association’s Scientific Sessions
Blomberg H, Gedeborg R, Berglund L, Karlsten R, Johansson J (2011) Poor chest compression quality with mechanical compressions in simulated cardiopulmonary resuscitation: A randomized, crossover manikin study. Resuscitation. 82 (10): 1332–7
Califf RM, Bengtson JR (1994) Cardiogenic shock. N Engl J Med. 330: 1724–1730
Cleland JG, Ghosh J, Freemantle N et al. (2004) Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail. 6: 501–508
Cruz DN, Perazella MA, Bellomo R, Corradi R, de Cal M, Kuang M, Ocampo C, Nalesso F, Ronco C (2006) Extracorporeal blood purification therapy for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Kidney Dis. 48: 361–371
De Backer D, Biston P, Devriendt J et al. (2010) Comparison of Dopamine and Norepinephrine in the Treatment of Shock. N Engl J Med. 362: 779–789
Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin, Berufsverband Deutscher Anästhesisten (2011) Perioperatives Nüchternheitsgebot bei operativen Eingriffen. Stellungnahme der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin und des Berufsverbandes Deutscher Anästhesisten. http://www.dgai.de/eev/EEV_2011_S_93-94.pdf (abgerufen: August 2012)
Enright T et al. (1989) Ann Allergy.62 (4): 302–5
European Society of Urogenital Radiology (2010) ESUR guidelines on contrast media, 7th edn. www.esur.org/Contrast-media.51.0.html
Follath F, Cleland JGF, Just H et al. (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe lowoutput heart failure (the LIDO study): a randomised double-blind trial. The Lancet. 360: 196–202
Gertz EW et al. (1992) J Am Coll Cardiol. 19 (5): 899–906
Gilbert EM, Hershberger RE, Wiechmann RJ, Movsesian MA, Bristow MR (1995) Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart. Chest. 108: 1524–1532
Goss JE et al. (1995) CathetCardiovascDiagn. 34 (2): 99–104
Gruberg L, Mintz GS, Mehran R. et al. (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with preexistent chronic renal insufficiency. J Am Coll Cardiol. 36: 1542–1548
Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes DR Jr. (2000) Cardiogenic shock complicating acute coronary syndromes. Lancet. 356: 749–756
Hintze G et al. (1999) Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. Eur J Endocrinol. 140 (3): 264–7
Hollenberg SM (2001) Cardiogenic shock. Crit Care Clin. 17: 391–410
Hollenberg SM, Kavinsky CJ, Parrillo JE (1999) Cardiogenic shock. Ann Intern Med. 131: 47–59
Hoste EA, De Waele JJ, Gevaert SA et al. (2009) Sodium bicarbonate for prevention of contrast- induced acute kidney injury: a systemic review and meta-analysis. Nephrol Dial Transplant International Collaborative Study of Severe Anaphylaxis (2003) Pharmacoepidemiolog Drug Saf. 12 (3): 195–202
Kane GC, Doyle BJ, Lerman A et al. (2008) Ultra-low contrast volumes reduce rates of contrast- induced nephropathy in patients with chronic kidney disease undergoing coronary angio- graphy. J Am Coll Cardiol. 51: 89–90
Katzberg RW, Newhouse JH (2010) Intravenous contrast mediuminduced nephrotoxicity: is the medical risk really as great as we have com to believe? Radiology. 256: 21–28
Kelly AM, Dwamena B, Cronin P et al. (2008) Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 148: 284–294
Koreny M, Karth GD, Geppert A et al. (2002) Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med. 112: 115–119
Koreny M, Karth GD, Geppert A et al. (2002) Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med. 112: 115–119
Kotoku M, Tamura A, Naono S, Kadota J (2007) Sinus arrest caused by occlusion of the sinus node artery during percutaneous coronary intervention for lesions of the proximal right coronary artery. Heart Vessels. 22 (6): 389–92
Larsen AI, Hjørnevik A, Bonarjee V, Barvik S, Melberg T, Nilsen DW (2010) Coronary blood flow and perfusion pressure during coronary angiography in patients with ongoing mechanical chest compression: a report on 6 cases. Resuscitation. 81 (4): 493–7
Lembo NJ et al. (1991) Am J Cardiol. 67 (13): 1046–50
McCullough PA, Bertrand ME, Brinker JA, Stacul F (2006) A metaanalysis of the renal safety of isosmolar iodixanol compared with lower molar contrast media. J Am Coll Cardiol. 48: 692–699
Mehran R, Aymong EO, Nikolsky E et al. (2004) A simple risk score for prediction of contrast- induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 44: 1393–1399
Mehran R, Nikolsky E (2006) Contrast-induced nephropathy: Definition, epidemiology, and patients at risk. Kidney Int. 69: S 11–S 15
Menon V, Fincke R (2003) Cardiogenic shock: a summary of the randomized SHOCK trial. Congest Heart Fail. 9 (1): 35–9
Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS (2000) The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 36: 1071–1076
Metra M, Nodari S, rsquo et al. (2002) Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: A randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. Journal of the American College of Cardiology. 40: 1248–1258
Moiseyev VS, Poder P, Andrejevs N et al. (2002) Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, lacebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 23: 1422–1432
Nolan JP et al. (2010) European Resuscitation Council Guidelines for Resuscitation 2010. Resuscitation 81: 1219–1276
Nolte et al. (1996) Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. Eur J Endocrinol. 134 (3): 337–41
Ocker H, Semmel T (2011) Der Larynxtubus in der Notfallmedizin: Eine praxisorientierte Anwendungsanleitung. http://www.vbm-medical.de/cms/files/a5-1.0_06.08-de--web--.pdf (September 2011)
Patti G, Nusca A, Chello M et al. (2008) Usefulness of statin pretreatment to prevent contrast- induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. AmJ Cardio. 101: 279–285
Persson BP, Tepel M (2006) Contrast medium-induced nephropathy: The pathophysiology. Kidney Int. 69: S 8–S 10
Ring J et al. (1985) Int Arch Allergy Appl Immunol. 78 (1): 9–14
Sandler CM (2003) Contrast-agent induced acute renal dysfunction – is iodixanol the answer? N Engl J Med. 348 (6): 551–3
Schonenberger E, Muhler M, Dewey (2010) Komplikationen durch Kontrastmittelgabe. Was ist gesichert in der Prävention? Internist (Berl.). 51: 1516–1524
Thomsen HS, Morcos SK, Barrett BJ (2008) Contrast-induced nephropathy: The wheel has turned 360 degrees. Acta RadioI. 49: 646–657
Wagner H, Terkelsen CJ, Friberg H, Harnek J, Kern K, Lassen JF, Olivecrona GK (2010) Cardiac arrest in the catheterisation laboratory: a 5-year experience of using mechanical chest compressions to facilitate PCI during prolonged resuscitation efforts. Resuscitation. 81 (4): 383–7
Yamaguchi K et al. (1991) Radiology. 178 (2): 363–7
Weiterführende Links
Analgosedierung für diagnostische und therapeutische Maßnahmen bei Erwachsenen: http://www.dgai.de/eev/EEV_2011_S_121-128.pdf (abgerufen: August 2012)
Fachinformationen zu Clorazepat, Etomidate, Ketamin, Midazolam, Propofol, Remifentanil, Rocuronium, Sugammadex, Tranxillium und Ultiva: http://ch.oddb.org
Gebrauchsinformation Ketanest S: http://static.pfizer.de/fileadmin/pfizer.de/documents/gi/KetanestS_5-5_GI.pdf
Larynx-Tubus in der Notfallmedizin: http://www.vbm-medical.de/cms/files/a5-1.0_06.08-de–web–.pdf (abgerufen: August 2012)
Perioperatives Nüchternheitsgebot bei operativen Eingriffen: http://www.dgai.de/eev/EEV_2011_S_93-94.pdf (abgerufen: August 2012)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kaiser, E., Pollmann, J., Müller, M. (2013). Periprozedurale Komplikationen. In: Kaiser, E. (eds) Komplikationsmanagement im Herzkatheterlabor. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25601-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-25601-1_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25600-4
Online ISBN: 978-3-642-25601-1
eBook Packages: Medicine (German Language)